Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/02/049940
CTRI/2023/02/049940
Not yet recruiting
未知

COMPARISON OF 0.5% HYPERBARIC BUPIVACAINE, 0.5 % HYPERBARIC LEVOBUPIVACAINE AND 0.75% HYPERBARIC ROPIVACAINE IN INFRAUMBLICALELECTIVE SURGERIES UNDER SUBARACHNOID BLOCK.

Shweta shivhare0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: S923- Fracture of metatarsal bone(s)Health Condition 2: S820- Fracture of patellaHealth Condition 3: S723- Fracture of shaft of femurHealth Condition 4: O- Medical and SurgicalHealth Condition 5: N452- OrchitisHealth Condition 6: N432- Other hydroceleHealth Condition 7: N843- Polyp of vulvaHealth Condition 8: M165- Unilateral post-traumatic osteoarthritis of hipHealth Condition 9: M171- Unilateral primary osteoarthritisof knee

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: S923- Fracture of metatarsal bone(s)Health Condition 2: S820- Fracture of patellaHealth Condition 3: S723- Fracture of shaft of femurHealth Condition 4: O- Medical and SurgicalHealth Condition 5: N452- OrchitisHealth Condition 6: N432- Other hydroceleHealth Condition 7: N843- Polyp of vulvaHealth Condition 8: M165- Unilateral post-traumatic osteoarthritis of hipHealth Condition 9: M171- Unilateral primary osteoarthritisof knee
Sponsor
Shweta shivhare
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Shweta shivhare

Eligibility Criteria

Inclusion Criteria

  • •Age18 years \- 60 years
  • •\- ASA grade1 and 2
  • •\- Scheduled for elective infraumblical surgeries under subarachnoid block

Exclusion Criteria

  • •\-Lack of patientâ??s consent.
  • •\- Age \<18yrs and \>60yrs.
  • •\- ASA grade 3 and more.
  • •\- Patients with local skin site infections.
  • •\- Patients with hypersensitivity to any of the drugs used.
  • •\- Pregnant and lactating mothers.
  • •\- History of serious pulmonary disease, ischemic heart disease, renal/hepatic
  • •dysfunction, coronary artery, or cervical spine disease and patients with abnormal
  • •coagulation profile.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
To compare two spinal anaesthetic drug with additive for lower abdominal surgeriesHealth Condition 1: M238- Other internal derangements of knee
CTRI/2024/08/071933Dr Anul R Shinde
Completed
Not Applicable
COMPARING TWO LOCAL ANAESTHETIS FOR LOWER LIMB SURGERIES
CTRI/2021/09/036672ORTHO OPERATION THEATRE FIRST FLOOR ABVIMS AND DR RAM MANOHAR LOHIA HOSPITA80
Not yet recruiting
Not Applicable
COMPARISON STUDY INJECTION HEAVY BUPIVACAINE 0.5% VS INJECTION HEAVY BUPIVACAINE 0.5% WITH FENTANYL IN LOWER ABDOMINAL AND LOWER LIMB SURGERIES
CTRI/2023/06/054076Anurag Agarwal
Not yet recruiting
Not Applicable
COMPARISION OF TWO LOCAL ANESTHETIC DRUGS WITH ADJUVANT FOR SPINAL ANESTHESIA IN LOWER LIMB SURGERIES
CTRI/2023/03/050773BPS govt medical college
Not yet recruiting
Not Applicable
Comparison of two heavy bupivacaine in patients undegoing surgery below umbilicus under spinal anaesthsiaHealth Condition 1: O- Medical and Surgical
CTRI/2023/02/049812Department of Anaesthesia and Intensive Care